CompletedPhase 2NCT00004396
Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
Studying Acute intermittent porphyria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Center for Research Resources (NCRR)
- Principal Investigator
- Karl Elmo AndersonUniversity of Texas
- Intervention
- heme arginate(drug)
- Enrollment
- 32 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 1997
Study locations (2)
- Rockefeller University Hospital, New York, New York, United States
- University of Texas Medical Branch, Galveston, Texas, United States
Collaborators
University of Texas
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004396 on ClinicalTrials.govOther trials for Acute intermittent porphyria
Additional recruiting or active studies for the same condition.